CASE STUDY: Unlocking the softgel liquid formulation option for FEXO

Unlocking the softgel formulation option for FEXO using our deep eutectic solvent technology.

Fexofenadine is a widely used over-the-counter (OTC) drug. It is commercially available in a variety of presentations, including tablets, powder-filled capsules and suspensions. However, there is no fexofenadine liquid softgel formulation on the market due to the low solubility of fexofenadine in liquid excipients and the requirement of a high drug dose (180 mg). 


Download the case study to learn how we developed a single unit of softgel containing the required dose. 

This website uses cookies to track the usage of it.

More info